Sight Sciences, Inc.
Sight Sciences, Inc. is listed today as Sight Sciences, Inc.: market value, financials and filings are on its company page.
Funding rounds
5 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Nov 2020 | $23 M | No. 5 | $10 to $50 million | equity | SEC | |
| Mar 2020 | $30 M | No. 4 | $10 to $50 million | equity | SEC | |
| Aug 2019 | $31 M | No. 3 | $10 to $50 million | equity | SEC | |
| Jul 2017 | $20 M | No. 2 | $10 to $50 million | equity | SEC | |
| Oct 2015 | $7 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Sight Sciences, Inc., its revenue in fiscal 2025 came from these business segments: Interventional Glaucoma $75.72 million (98%), Interventional Dry Eye $1.64 million (2%).
Annual report (SEC XBRL) · Dec 2025
Sight Sciences, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2020).
SEC Form D · Dec 2020
The industry group it chose in its notices: Biotechnology.
SEC Form D · Dec 2020
Products and services#
No products or services of Sight Sciences, Inc. are on record.
Investors#
8 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Andrew Offer | Person | not stated | not stated | Held Series C preferred stock, director (Form 3, 2021) | SEC Form 3 |
| D1 Capital Partners L.P. | Fund or asset manager | not stated | not stated | Held Series E and F preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| HEP Partners LLC | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| HH-IOP Partners, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| HH Sight LLC | Other | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| HH Sight Partners GP, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| HH Sight Partners, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| KCK LTD. | Company | not stated | not stated | Held Series D preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 25 investors.
Largest shareholders today
Institutions holding Sight Sciences, Inc. shares, as of Sep 30, 2026.
- Long Focus Capital Management, LLC$36 M6.92%
- BlackRock, Inc.$31 M6.05%
- Pathstone Holdings, LLC$20 M3.93%
- Vanguard Capital Management LLC$15 M2.94%
- Geode Capital Management, LLC$9 M1.76%
- B Group, Inc.$9 M1.75%
- Acadian Asset Management LLC$8 M1.52%
- State Street Corp$8 M1.51%
- Millennium Management LLC$7 M1.28%
- Dimensional Fund Advisors LP$3 M0.67%
- Northern Trust Corp$3 M0.64%
- D. E. Shaw & Co., Inc.$3 M0.63%
- Charles Schwab Investment Management Inc$3 M0.58%
- Panagora Asset Management Inc$3 M0.54%
- Next Century Growth Investors LLC$3 M0.52%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Jesse Selnick | Executive officer | Dec 2020 |
| Paul Badawi | Executive officer | Dec 2020 |
| Stephen Thau | Executive officer | Sep 2019 |
| Andrew Offer | Director | Dec 2020 |
| David Badawi | Director | Dec 2020 |
| Don Zurbay | Director | Dec 2020 |
| Erica Rogers | Director | Dec 2020 |
| Mack Hicks | Director | Dec 2020 |
| Paul Badawi | Director | Dec 2020 |
| Staffan Encrantz | Director | Dec 2020 |
| Valeska Schroeder | Director | Dec 2020 |
| Carter Meyer | Director | Apr 2020 |
| Tommy Hicks | Director | Oct 2015 |
Went public since 2021. Its SEC number is that of a company listed on a stock exchange.